Dr. Marc L. Bernstein, MD

Dr. Bernstein practices at Suncoast Endoscopy of Sarasota in Sarasota, Florida.

Dr. Bernstein's NPI, 1396040366, was assigned on January 21, 2011. Dr. Bernstein graduated from Florida State University College Of Medicine in 2008. Dr. Bernstein holds Florida license ME137780.

Dr. Bernstein's primary practice is Suncoast Endoscopy of Sarasota, at 2089 Hawthorne St Suite 100, Sarasota, FL 34239. The practice phone is (941) 952-1145.

Dr. Bernstein's primary practice is Suncoast Endoscopy of Sarasota in Sarasota, Florida. Dr. Bernstein is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is Florida Digestive Health Specialists. Dmand AI also links Dr. Bernstein to 1 more hospital, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bernstein practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Bernstein's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Bernstein is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Bernstein's licenses on file in 3 states: Florida, Georgia and Pennsylvania.

Dmand AI lists acid reflux, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroduodenitis and gastroenteritis among the conditions Dr. Bernstein treats.

CMS data shows 2,240 Medicare services from Dr. Bernstein across 17 procedure codes in 2024, for 1,077 Medicare patients. Medicare paid $233,420 for them.

CMS counts 1,077 Medicare patients who saw Dr. Bernstein in 2024. The largest group is 65 to 74, with 479 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bernstein's median patient age at 70, with 48% women.

In 2024, Dr. Bernstein wrote 1,577 Medicare Part D claims for 535 patients. 77% of them were for generic drugs. CMS names the drug for 1,336 of them, across 23 drugs with 11 or more claims each, at $336,060 in total drug cost. In 2023, CMS named 1,218 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Bernstein for performance year 2024, reported as part of a group. Dr. Bernstein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bernstein as offering telehealth. CMS counts 369 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Bernstein, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Bernstein in 2025. Dr. Bernstein's most frequent co-authors are Adam Charles Ehrlich, MD, MPH, Frank Karpf Friedenberg and Jonathan Isaac Gotfried, MD.

CMS Open Payments shows 1,010 general payments to Dr. Bernstein from 54 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 60% of the total. Eli Lilly and Company paid the most, $185,632.

Dr. Bernstein graduated from Florida State University College Of Medicine in 2008.

Dr. Bernstein is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.